133 related articles for article (PubMed ID: 35131366)
41. A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.
Cao Y; Duan H; Su A; Xu L; Lai B
Aging (Albany NY); 2022 Jul; 14(13):5590-5610. PubMed ID: 35802774
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
He D; Zhang X; Tu J
Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
[TBL] [Abstract][Full Text] [Related]
43. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract][Full Text] [Related]
44. GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
Peng Q; Xie T; Wang Y; Ho VW; Teoh JY; Chiu PK; Ng CF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203661
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.
Wang B; Zhong JL; Li HZ; Wu B; Sun DF; Jiang N; Shang J; Chen YF; Xu XH; Lu HD
Life Sci; 2021 Jul; 277():119452. PubMed ID: 33831430
[TBL] [Abstract][Full Text] [Related]
46. Pan-cancer analysis of the prognostic value of C12orf75 based on data mining.
Cai G; Jin G; Liang J; Li G; Chen X; Liang H; Ding Z
Aging (Albany NY); 2021 Jun; 13(11):15214-15239. PubMed ID: 34074799
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the role of Frizzled 2 in different cancer types.
Zhou M; Sun X; Zhu Y
FEBS Open Bio; 2021 Apr; 11(4):1195-1208. PubMed ID: 33565732
[TBL] [Abstract][Full Text] [Related]
48. A zinc finger protein gene signature enables bladder cancer treatment stratification.
Zhang J; Zhang C; Cao P; Zheng X; Yu B; Cao H; Gao Z; Zhang F; Wu J; Cao H; Hao C; Sun Z; Wang W
Aging (Albany NY); 2021 May; 13(9):13023-13038. PubMed ID: 33962398
[TBL] [Abstract][Full Text] [Related]
49. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
[TBL] [Abstract][Full Text] [Related]
50.
Wang J; Shen C; Zhang J; Zhang Y; Liang Z; Niu H; Wang Y; Yang X
DNA Cell Biol; 2021 Jun; 40(6):798-810. PubMed ID: 34030484
[TBL] [Abstract][Full Text] [Related]
51. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
[TBL] [Abstract][Full Text] [Related]
52. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
53. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
[TBL] [Abstract][Full Text] [Related]
54. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Wang Z; Du Y
Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
[TBL] [Abstract][Full Text] [Related]
55. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
56. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
Chen Y; Zhao H; Xiao Y; Shen P; Tan L; Zhang S; Liu Q; Gao Z; Zhao J; Zhao Y; Guo Y; Feng Y
Aging (Albany NY); 2021 Jun; 13(12):16248-16266. PubMed ID: 34135128
[TBL] [Abstract][Full Text] [Related]
57. A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.
Jia Y; Tian Q; Yang K; Liu Y; Liu Y
Biomed Res Int; 2021; 2021():5862941. PubMed ID: 34845438
[TBL] [Abstract][Full Text] [Related]
58. Pan-cancer analysis reveals the expression, genetic alteration and prognosis of pyroptosis key gene GSDMD.
Qiu S; Hu Y; Dong S
Int Immunopharmacol; 2021 Dec; 101(Pt A):108270. PubMed ID: 34700129
[TBL] [Abstract][Full Text] [Related]
59. The landscape of prognostic and immunological role of myosin light chain 9 (MYL9) in human tumors.
Lv M; Luo L; Chen X
Immun Inflamm Dis; 2022 Feb; 10(2):241-254. PubMed ID: 34729929
[TBL] [Abstract][Full Text] [Related]
60. Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.
Liu JN; Kong XS; Huang T; Wang R; Li W; Chen QF
Front Immunol; 2020; 11():2048. PubMed ID: 33072070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]